Survival analyses of the ZeOxaNMulti trial: Follow-up randomized, double-blinded, placebo-controlled trial of oral PMA-zeolite to prevent chemotherapy-induced side effects, especially peripheral neuropathy

• Main Authors: Maria Giuseppa Vitale (Author), Anna Crispo (Author), Dario Arundine (Author), Riccardo Ronga (Author), Carmela Barbato (Author), Assunta Luongo (Author), Francesco Habetswallner (Author), Bernardo Maria De Martino (Author), Angela Maione (Author), Sandra Eisenwagen (Author), Giovanna Vitale (Author), Ferdinando Riccardi (Author)
• Format: Book
• Published: Frontiers Media S.A., 2022-11-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Following the previously published results of the clinical randomized ZeOxaNMulti trial, we evaluated the potential of the tested product PMA-ZEO (Multizeo Med) in the prevention of chemotherapy-induced side effects (especially peripheral neuropathy) within a 30-month follow-up analysis. The aim was...